Navigation Links
Molecule that usually protects infection-fighting cells may cause plaque deposits inside arteries

A molecule that usually protects the body's infection-fighting cells might also contribute to fatty buildups that coat arteries and lead to heart disease, UT Southwestern Medical Center researchers have found.

The molecule, called apoptosis inhibitor of macrophage or AIM, inhibits cell death in macrophages, which circulate in the bloodstream and help the body fend off infection and foreign substances. The AIM-protected macrophages go on to encourage buildup of fats on the interior walls of arteries, according to Dr. Toru Miyazaki, senior author of a study that appears in the March issue of the journal Cell Metabolism.

"We found that AIM is highly expressed in certain macrophages and that lack of AIM dramatically decreased early atherosclerotic lesion development in mice," Dr. Miyazaki said. "These results may imply a novel therapeutic application of AIM regulation for prevention of atherosclerosis in the future. Most importantly and attractively for patients, this approach may not need dietary restriction."

Dr. Miyazaki, associate professor in the Center for Immunology and of pathology, and his colleagues first discovered the protective role of AIM six years ago. In the current study, scientists exposed mice lacking AIM to a fatty diet that would normally induce atherosclerosis.

After several weeks, researchers found little to no atherosclerotic lesions. Comparatively, in mice that had normal AIM function, there was marked presence of plaque deposits in the arteries following a diet of high-fat food.

"This was dramatic evidence that showed suppressing AIM function translates into prevention of atherosclerosis," Dr. Miyazaki said.

Atherosclerosis, known as "hardening of the arteries," occurs when the inside walls of an artery become thicker and less elastic.

This narrows the space for blood flow and can lead to angina and heart attacks in some people. Fatty buildups occur on the inner lining of an artery and grad
'"/>

Source:University of Texas Southwestern Medical Center at Dallas


Page: 1 2

Related biology news :

1. DNA Molecules Used To Assemble Nanoparticles
2. Duke Chemists Isolating Individual Molecules Of Toxic Protein In Alzheimers, Parkinsons Disease
3. Successful Test Of Single Molecule Switch Opens The Door To Biomolecular Electronics
4. Touching Molecules With Your Bare Hands
5. Team Invents Device For Weighing Individual Molecules
6. Missing Receptor Molecule Causes Tumor Growth
7. Molecule by molecule, new assay shows real-time gene activity
8. Molecule does more than slice and dice RNA
9. Molecules in blood foretell development of preeclampsia
10. Molecule that destroys bone also protects it, new research shows
11. Bound for destruction: Ubiquitination protects against improper Notch signaling

Post Your Comments:
(Date:11/5/2009)... , The National Association of Biology Teachers (...or of biological sciences at Naugatuck Valley Comm...th the 2009 Evolution Education Award during the N...be held 11-14 November 2009 in Denver, Colorado. ,... the American Institute of Biological Sciences,(A...
(Date:11/4/2009)... , Heavy traffic corridors in the cities of Long ...ant proportion of preventable childhood asthma, an...ons on the disease has likely been underestimated,...thern California (USC). , The study, which appe...of Public Health , estimated that nine percent of ...
(Date:11/4/2009)... , PORTOLA VALLEY, Calif., Oct. 19 /PRNewswir...nced molecular sensing and imaging devices which s...today that it has signed exclusive distribution de...and Sensors. The markets covered include Australi...urg (Benelux), Suriname, Italy, France, Spain, Por...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2USC study finds big air pollution impacts on local communities 2Spectros Signs New International Distribution Deals 2Illinois Medical District Recognizes Officers of its District Security Group 47860 1Illinois Medical District Recognizes Officers of its District Security Group 47860 2Pharmaxis Announces Placement of 2447 Million and Share Purchase Plan 12459 1Pharmaxis Announces Placement of 2447 Million and Share Purchase Plan 12459 2Orlando Dermatology Aesthetic 26 Clinical 28ODAC 29 Conference Announces Its 2010 Event 47854 1Orlando Dermatology Aesthetic 26 Clinical 28ODAC 29 Conference Announces Its 2010 Event 47854 2
...ered that two microRNA (miRNA) molecules help cont...of B-cell chronic lymphocytic leukemia (B-CLL), th...r findings, published in the December 15 issue of ...ing as powerful regulators of gene expression in c... drug treatment, the investigators say. , In t...
...blem could be eliminated simply by dusting slag on...& Industry, the magazine of the SCI. , In the ...f damage annually. , Researcher David Cowen and...t applying slag to wheat growing in greenhouses ha...orporate the silica and express it as spiky struct...
... of plants to defend themselves by accumulating hi...me insects, and that such adaptation potentially e...ites may in turn evolve to deal with high levels o...zabeth Pilon-Smits of Colorado State University an...rnia, Berkeley, appear in the November 21st issue ...
Other Biology News:Pair of microRNA molecules controls major oncogene in most common leukemia 2New moth variety disarms plants guarded by selenium 2
(Date:11/9/2009)...a research industry first, allowing veterinary res...afety study data to be managed in one software app... NJ (PRWEB) November 9, 2009 -- Xybion Medical Sys...™ VM, an integrated enterprise software solu...d care of veterinary research subjects. Pristima&t...
(Date:11/8/2009)... Complete Genomics, a third-generation human genom...of a report in the journal Science describing it...nalysis of sequence data from three complete human...omes sequenced on the proof-of-principle genomic D...to $1,726 for 45x coverage for the samples describ...
(Date:11/6/2009)...tCall/ -- BioSpecifics Technologies Corp. (Nasdaq:...irst-in-class collagenase-based products, today an...r ended September 30, 2009. ,, "We were extrem...,s Arthritis Advisory Committee unanimously recomm...TM) for the treatment of Dupuytren,s disease, and ...
(Date:11/6/2009)...wire/ -- EUCODIS Bioscience, a company,developing,... for the,chemical industry announced today that it...dus, the leading biopharmaceutical company in Lati...Bioscience exclusive access - for the search,of en...ection of,psychrophilic bacteria strains and other...
Breaking Biology Technology:Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2
...in Shipping Dronabinol Soft Gel Capsules Immediate...ical Companies, Inc. (NYSE: PRX ) today announced... Food and Drug Administration for its,Abbreviated ...sion of,Solvay Pharmaceutical,s Marinol(R), a CIII... treat nausea and vomiting associated with cancer,...
...alif., June 30 As most doctors face the,Congressi...s next week,Arcadian Health Plan, Inc. announced t...network physicians at the same level of payment as...o supporting its physician,partners as they contin...,members., Arcadian recognizes the value and qual...
...H, Mass. June 30 Joseph B. Bolen, Ph.D., CSO,of M... Cancer track IBC,Life Sciences Drug Discovery & D...nd Exhibition taking place August 4-7 at the World.... The cancer track presentations will,focus on the...ncers, and,Clinical Biomarkers., Bolen has confir...
Other Biology Technology:Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules 2Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules 3Joseph B. Bolen, Ph.D. from Millennium to Conference Chair Cancer Sessions at IBC's Drug Discovery & Development of Innovative Therapeutics Conference 2
...ystem - dUTP with CyScribe GFX Purification Kit, 5...f Cy3- and Cy5-labeled cDNA.Optimized reagents are...purification.Flexible and optimized protocols can ...her Cy3- or Cy5-labeled nucleotides.Reliable purif...
Canine serum from Equitech-Bio
Rabbit Anti-TOLLIP Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
... mA, 100 W maximum.Constant voltage, constant curr...ts in settings and read-outs for precision and rep...tstanding choice for non-IEF ultrathin flatbed gel...Electrophoresis Systems & Standards & Reagents, Po...
Biology Products: